2012 Biotechnology Research Review

BCC Research
December 1, 2012
143 Pages - SKU: WA4910218
A comprehensive analysis of the agricultural biotechnology industry, with an emphasis on products and technologies that are commercially important in the 2012 to 2017 time period.

An in-depth look at the demand for biosimilar drugs that have entered the market worldwide and forecasts the growth prospects for these products.

A detailed analysis of the kinase inhibitors industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2011 through 2016.


Additional Information

REPORT SCOPE

FOREWORD

In 2012, there were about 1.6 million people in the U.S. working in bioscience-based jobs, who took home an average salary in the mid-$80,000s. The biotech industry’s wages are about 80% higher than the average private sector job in the U.S., and while biotech saw a small decline in the last five years, job losses weren’t as bad as in industries like aerospace or software.

Venture capital flow into biotech has steadily risen during the last four or five years, and in the preceding year there were 35 big exits in biotech and medical devices. Taken together, those 35 big deals in the life sciences generated $8.8 billion in up-front returns to investors. That figure inflates to $12.7 billion when counting the future milestone payments, though there is nothing guaranteed except for optimism. This has helped to offset some of the reduction in NIH direct spending, post financial crisis. Overall, the biotech sector remains vibrant and positive.

More Research & Development reports by BCC Research

Nanoparticles in Biotechnology, Drug Development and Drug Delivery by BCC Research
Nanoparticles in Biotechnology, Drug Development and Drug Delivery The global market for nanoparticles in biotechnology and pharmaceuticals reached nearly $25.0 billion in 2013. This market ...
Antibiotics: Technologies and Global Markets by BCC Research
Pharmaceuticals: Antibiotics: Technologies and Global Markets REPORT HIGHLIGHTS The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to ...
Healthcare: Therapeutics for Women's Health - Technologies and Global Markets by BCC Research
Healthcare: Therapeutics for Women's Health - Technologies and Global Markets REPORT HIGHLIGHTS The global market for women’s health therapeutics was worth nearly $18.3 billion ...
2013 Pharmaceuticals Research Review by BCC Research
2013 Pharmaceuticals Research Review The global anticoagulant drug market was valued at nearly $5.8 billion in 2011 and should reach nearly $5.7 billion in 2012. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 950  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!